Serum antioxidant status in patients with systemic sclerosis

Area of Science:

• Biochemistry
• Pathophysiology
• Clinical Medicine

Background:

• Vascular endothelial dysfunction is a key factor in systemic sclerosis pathogenesis.
• Oxidative stress and reduced serum antioxidants are implicated in this dysfunction.
• Systemic sclerosis is a significant human disease characterized by vascular abnormalities.

Purpose of the Study:

• To compare serum antioxidant levels in systemic sclerosis patients versus healthy controls.
• To investigate the role of oxidative stress in systemic sclerosis.
• To identify potential therapeutic targets for systemic sclerosis.

Main Methods:

• A case-control study involving 16 systemic sclerosis patients and 16 age/sex-matched healthy controls.
• Serum levels of antioxidants including glutathione (GSH), nitric oxide (NO), malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPX) were measured.
• Spectrophotometry was used for antioxidant assays, with one-sample t-tests for statistical analysis.

Main Results:

• Serum levels of NO, GSH, and SOD were significantly decreased in systemic sclerosis patients (P < 0.001).
• Levels of GPX and MDA were normal to increased in patients.
• Median antioxidant levels in controls were SOD-4.14 units/ml, GSH-4.76 units/ml, NO-5.58 nmol/l, MDA-0.53 nmol/l, and GPX-49 μmol/l.

Conclusions:

• Depleted serum antioxidants and oxidative stress are likely contributors to vascular dysfunction in systemic sclerosis.
• Micronutrient antioxidant supplementation could be a valuable therapeutic strategy.
• Further research into antioxidant therapies for systemic sclerosis is warranted.